Ellen M. Zimmermann

5.7k total citations · 2 hit papers
108 papers, 4.3k citations indexed

About

Ellen M. Zimmermann is a scholar working on Genetics, Epidemiology and Surgery. According to data from OpenAlex, Ellen M. Zimmermann has authored 108 papers receiving a total of 4.3k indexed citations (citations by other indexed papers that have themselves been cited), including 60 papers in Genetics, 31 papers in Epidemiology and 23 papers in Surgery. Recurrent topics in Ellen M. Zimmermann's work include Inflammatory Bowel Disease (49 papers), Microscopic Colitis (23 papers) and Autoimmune and Inflammatory Disorders (11 papers). Ellen M. Zimmermann is often cited by papers focused on Inflammatory Bowel Disease (49 papers), Microscopic Colitis (23 papers) and Autoimmune and Inflammatory Disorders (11 papers). Ellen M. Zimmermann collaborates with scholars based in United States, Israel and United Kingdom. Ellen M. Zimmermann's co-authors include William J. Sandborn, Florian Rieder, Feza H. Remzi, John W. Yunginger, Arik Dahan, Jeremy Adler, P. Kay Lund, Gerald J. Gleich, Shimon Ben‐Shabat and Peter Higgins and has published in prestigious journals such as SHILAP Revista de lepidopterología, The Journal of Immunology and Gastroenterology.

In The Last Decade

Ellen M. Zimmermann

105 papers receiving 4.2k citations

Hit Papers

Crohn's disease complicated by strictures: a systematic r... 2013 2026 2017 2021 2013 2018 100 200 300

Peers

Ellen M. Zimmermann
Vijay Yajnik United States
Brian D. Tait Australia
Mario R. Ehlers United States
H. J. F. Hodgson United Kingdom
Terrence A. Barrett United States
Michael Fried Switzerland
Ramnik J. Xavier United States
Alan D. Levine United States
Ellen M. Zimmermann
Citations per year, relative to Ellen M. Zimmermann Ellen M. Zimmermann (= 1×) peers Sander van Deventer

Countries citing papers authored by Ellen M. Zimmermann

Since Specialization
Citations

This map shows the geographic impact of Ellen M. Zimmermann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ellen M. Zimmermann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ellen M. Zimmermann more than expected).

Fields of papers citing papers by Ellen M. Zimmermann

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ellen M. Zimmermann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ellen M. Zimmermann. The network helps show where Ellen M. Zimmermann may publish in the future.

Co-authorship network of co-authors of Ellen M. Zimmermann

This figure shows the co-authorship network connecting the top 25 collaborators of Ellen M. Zimmermann. A scholar is included among the top collaborators of Ellen M. Zimmermann based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ellen M. Zimmermann. Ellen M. Zimmermann is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Zimmermann, Ellen M., et al.. (2023). Vulnerable Patients with Inflammatory Bowel Disease. 25. 1 indexed citations
3.
Marković, Milica, Shimon Ben‐Shabat, Aaron Aponick, et al.. (2022). Prodrug-Based Targeting Approach for Inflammatory Bowel Diseases Therapy: Mechanistic Study of Phospholipid-Linker-Cyclosporine PLA2-Mediated Activation. International Journal of Molecular Sciences. 23(5). 2673–2673. 10 indexed citations
4.
Marković, Milica, Shimon Ben‐Shabat, Yifat Miller, et al.. (2022). PLA2-Triggered Activation of Cyclosporine-Phospholipid Prodrug as a Drug Targeting Approach in Inflammatory Bowel Disease Therapy. Pharmaceutics. 14(3). 675–675. 8 indexed citations
5.
Arukha, Ananta Prasad, Meerambika Mishra, Jyoti K. Jha, et al.. (2021). Lactococcus lactis Delivery of Surface Layer Protein A Protects Mice from Colitis by Re-Setting Host Immune Repertoire. Biomedicines. 9(9). 1098–1098. 8 indexed citations
6.
Marković, Milica, et al.. (2020). Phospholipid Cyclosporine Prodrugs Targeted at Inflammatory Bowel Disease (IBD) Treatment: Design, Synthesis, and in Vitro Validation. ChemMedChem. 15(17). 1639–1644. 6 indexed citations
7.
Marković, Milica, Shimon Ben‐Shabat, Aaron Aponick, Ellen M. Zimmermann, & Arik Dahan. (2020). Lipids and Lipid-Processing Pathways in Drug Delivery and Therapeutics. International Journal of Molecular Sciences. 21(9). 3248–3248. 60 indexed citations
9.
Marković, Milica, Arik Dahan, Shahar Keinan, et al.. (2019). Phospholipid-Based Prodrugs for Colon-Targeted Drug Delivery: Experimental Study and In-Silico Simulations. Pharmaceutics. 11(4). 186–186. 16 indexed citations
10.
Marković, Milica, Shimon Ben‐Shabat, Shahar Keinan, et al.. (2019). Molecular Modeling-Guided Design of Phospholipid-Based Prodrugs. International Journal of Molecular Sciences. 20(9). 2210–2210. 16 indexed citations
11.
Dahan, Arik, Milica Marković, Noa Cohen, et al.. (2017). Phospholipid-drug conjugates as a novel oral drug targeting approach for the treatment of inflammatory bowel disease. European Journal of Pharmaceutical Sciences. 108. 78–85. 29 indexed citations
12.
Dahan, Arik, Milica Marković, Shahar Keinan, et al.. (2017). Computational modeling and in-vitro/in-silico correlation of phospholipid-based prodrugs for targeted drug delivery in inflammatory bowel disease. Journal of Computer-Aided Molecular Design. 31(11). 1021–1028. 13 indexed citations
13.
Bruining, David H., Gauraang Bhatnagar, Jordi Rimola, et al.. (2015). CT and MR enterography in Crohn’s disease: current and future applications. Abdominal Imaging. 40(5). 965–974. 36 indexed citations
14.
Reingold, Laura J., Phyllissa Schmiedlin‐Ren, Diane E. Bender, et al.. (2013). Development of a Peptidoglycan–Polysaccharide Murine Model of Crohnʼs Disease. Inflammatory Bowel Diseases. 19(6). 1238–1244. 13 indexed citations
15.
Belyakov, Igor M., Ellen M. Zimmermann, Dmitry Isakov, et al.. (2012). Effect of targeted drug delivery with G5-MTX dendrimers on induced T regulatory (iTreg) CD4+ T cells in an inflammatory bowel disease (IBD) colitis model (52.1). The Journal of Immunology. 188(1_Supplement). 52.1–52.1. 3 indexed citations
16.
Higgins, Peter, Elaine M. Caoili, Michael Zimmermann, et al.. (2006). Computed tomographic enterography adds information to clinical management in small bowel Crohnʼs disease. Inflammatory Bowel Diseases. 13(3). 262–268. 89 indexed citations
17.
Kesisoglou, Filippos, Phyllissa Schmiedlin‐Ren, David Fleisher, Blake J. Roessler, & Ellen M. Zimmermann. (2006). Restituting intestinal epithelial cells exhibit increased transducibility by adenoviral vectors. The Journal of Gene Medicine. 8(12). 1379–1392. 10 indexed citations
18.
Zhou, Simon, et al.. (1999). Regulation of Paracellular Absorption of Cimetidine and 5-Aminosalicylate in Rat Intestine. Pharmaceutical Research. 16(11). 1781–1785. 25 indexed citations
19.
Haskill, Stephen, et al.. (1994). Tissue interleukin 1 and interleukin-1 receptor antagonist expression in enterocolitis in resistant and susceptible rats. Gastroenterology. 106(4). 960–972. 110 indexed citations
20.
Zimmermann, Ellen M., et al.. (1993). Insulinlike growth factor I and interleukin 1β messenger RNA in a rat model of granulomatous enterocolitis and hepatitis. Gastroenterology. 105(2). 399–409. 69 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026